Fused in Sarcoma Neuropathology in Neurodegenerative Disease
Author(s) -
Ian R. Mackenzie,
Manuela Neumann
Publication year - 2017
Publication title -
cold spring harbor perspectives in medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.853
H-Index - 105
eISSN - 2472-5412
pISSN - 2157-1422
DOI - 10.1101/cshperspect.a024299
Subject(s) - amyotrophic lateral sclerosis , neuropathology , frontotemporal dementia , pathological , frontotemporal lobar degeneration , pathology , disease , sarcoma , medicine , dementia , neuroscience , biology
Abnormal intracellular accumulation of the fused in sarcoma (FUS) protein is the characteristic pathological feature of cases of familial amyotrophic lateral sclerosis (ALS) caused by FUS mutations (ALS- FUS ) and several uncommon disorders that may present with sporadic frontotemporal dementia (FTLD-FUS). Although these findings provide further support for the concept that ALS and FTD are closely related clinical syndromes with an overlapping molecular basis, important differences in the pathological features and results from experimental models indicate that ALS- FUS and FTLD-FUS have distinct pathogenic mechanisms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom